HEADER DNA-BINDING PROTEIN 11-AUG-04 1W60 TITLE NATIVE HUMAN PCNA COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROLIFERATING CELL NUCLEAR ANTIGEN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PCNA, CYCLIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS DNA, REPLICATION, PROCESSIVITY, ONCOGENE, DNA-BINDING KEYWDS 2 PROTEIN, DNA REPLICATION, DNA-BINDING SYSTEMIC LUPUS KEYWDS 3 ERYTHEMATOSUS EXPDTA X-RAY DIFFRACTION AUTHOR G.KONTOPIDIS,S.WU,D.ZHELEVA,P.TAYLOR,C.MCINNES,D.LANE, AUTHOR 2 P.FISCHER,M.WALKINSHAW REVDAT 3 24-FEB-09 1W60 1 VERSN REVDAT 2 16-FEB-05 1W60 1 JRNL REVDAT 1 13-JAN-05 1W60 0 JRNL AUTH G.KONTOPIDIS,S.WU,D.ZHELEVA,P.TAYLOR,C.MCINNES, JRNL AUTH 2 D.LANE,P.FISCHER,M.WALKINSHAW JRNL TITL STRUCTURAL AND BIOCHEMICAL STUDIES OF HUMAN JRNL TITL 2 PROLIFERATING CELL NUCLEAR ANTIGEN COMPLEXES JRNL TITL 3 PROVIDE A RATIONALE FOR CYCLIN ASSOCIATION AND JRNL TITL 4 INHIBITOR DESIGN JRNL REF PROC.NATL.ACAD.SCI.USA V. 102 1871 2005 JRNL REFN ISSN 0027-8424 JRNL PMID 15681588 JRNL DOI 10.1073/PNAS.0406540102 REMARK 2 REMARK 2 RESOLUTION. 3.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 11.0 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 8605 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.19695 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.8 REMARK 3 FREE R VALUE TEST SET COUNT : 430 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3926 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 58 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.8 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.33 REMARK 3 B22 (A**2) : -0.33 REMARK 3 B33 (A**2) : 0.49 REMARK 3 B12 (A**2) : -0.16 REMARK 3 B13 (A**2) : 0.0 REMARK 3 B23 (A**2) : 0.0 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.612 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.456 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 26.46 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1W60 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-AUG-04. REMARK 100 THE PDBE ID CODE IS EBI-15157. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-FEB-00 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.60 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.3 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.2 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.4 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 35% PEGMME 2K, REMARK 280 0.1M NA ACETATE (PH4.6), 0.2M AS. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 82.89200 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 41.44600 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 71.78658 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 124.33800 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 71.78658 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 143.57316 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 FUNCTION: THIS PROTEIN IS AN AUXILIARY PROTEIN OF DNA POLYMERASE REMARK 400 DELTA AND IS INVOLVED IN THE CONTROL OF EUKARYOTIC DNA REPLICATION REMARK 400 BY INCREASING THE POLYMERASE'S PROCESSIBILITY DURING ELONGATION OF REMARK 400 THE LEADING STRAND. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 256 REMARK 465 ASP A 257 REMARK 465 GLU A 258 REMARK 465 GLU A 259 REMARK 465 GLY A 260 REMARK 465 SER A 261 REMARK 465 GLU B 256 REMARK 465 ASP B 257 REMARK 465 GLU B 258 REMARK 465 GLU B 259 REMARK 465 GLY B 260 REMARK 465 SER B 261 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 187 - OD2 ASP A 189 2.16 REMARK 500 O ASP B 189 - N GLU B 191 2.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TRP B 28 NE1 TRP B 28 CE2 0.112 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 163 -148.45 -147.87 REMARK 500 ASN A 187 -161.74 -116.16 REMARK 500 ASP A 189 -146.57 -147.31 REMARK 500 LYS A 190 -144.67 -116.40 REMARK 500 GLU A 193 174.82 44.94 REMARK 500 ALA A 194 -94.32 -144.84 REMARK 500 VAL A 195 72.95 -175.06 REMARK 500 GLU A 198 59.25 -110.09 REMARK 500 ASN B 24 -6.79 -140.95 REMARK 500 SER B 31 122.69 178.81 REMARK 500 SER B 32 -91.74 25.50 REMARK 500 ASP B 86 116.34 -29.54 REMARK 500 ASN B 95 53.48 -107.38 REMARK 500 GLN B 108 168.04 -38.86 REMARK 500 GLU B 109 124.71 95.18 REMARK 500 LYS B 110 50.30 75.76 REMARK 500 ALA B 163 -143.98 -147.69 REMARK 500 LEU B 182 -83.69 -79.95 REMARK 500 SER B 183 165.37 71.48 REMARK 500 ASN B 187 -106.68 -65.67 REMARK 500 VAL B 188 32.18 154.93 REMARK 500 LYS B 190 15.52 -47.73 REMARK 500 GLU B 191 131.27 -18.09 REMARK 500 ALA B 194 -151.52 177.61 REMARK 500 VAL B 195 -69.04 -158.21 REMARK 500 THR B 196 129.98 44.64 REMARK 500 SER B 230 48.01 -150.82 REMARK 500 ALA B 231 135.73 25.52 REMARK 500 ASP B 232 -13.23 83.89 REMARK 500 LYS B 254 -148.62 -80.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AXC RELATED DB: PDB REMARK 900 HUMAN PCNA REMARK 900 RELATED ID: 1U76 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HPCNA BOUND TO RESIDUES REMARK 900 452-466 OF THEDNA POLYMERASE-DELTA-P66 REMARK 900 SUBUNIT REMARK 900 RELATED ID: 1U7B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HPCNA BOUND TO RESIDUES REMARK 900 331-350 OF THEFLAP ENDONUCLEASE-1 (FEN1) REMARK 900 RELATED ID: 1VYJ RELATED DB: PDB REMARK 900 STRUCTURAL AND BIOCHEMICAL STUDIES OF HUMAN REMARK 900 PCNA COMPLEXES PROVIDE THE BASIS FOR REMARK 900 ASSOCIATION WITH CDK/CYCLIN AND RATIONAL FOR REMARK 900 INHIBITOR DESIGN REMARK 900 RELATED ID: 1VYM RELATED DB: PDB REMARK 900 NATIVE HUMAN PCNA DBREF 1W60 A 1 261 UNP P12004 PCNA_HUMAN 1 261 DBREF 1W60 B 1 261 UNP P12004 PCNA_HUMAN 1 261 SEQRES 1 A 261 MET PHE GLU ALA ARG LEU VAL GLN GLY SER ILE LEU LYS SEQRES 2 A 261 LYS VAL LEU GLU ALA LEU LYS ASP LEU ILE ASN GLU ALA SEQRES 3 A 261 CYS TRP ASP ILE SER SER SER GLY VAL ASN LEU GLN SER SEQRES 4 A 261 MET ASP SER SER HIS VAL SER LEU VAL GLN LEU THR LEU SEQRES 5 A 261 ARG SER GLU GLY PHE ASP THR TYR ARG CYS ASP ARG ASN SEQRES 6 A 261 LEU ALA MET GLY VAL ASN LEU THR SER MET SER LYS ILE SEQRES 7 A 261 LEU LYS CYS ALA GLY ASN GLU ASP ILE ILE THR LEU ARG SEQRES 8 A 261 ALA GLU ASP ASN ALA ASP THR LEU ALA LEU VAL PHE GLU SEQRES 9 A 261 ALA PRO ASN GLN GLU LYS VAL SER ASP TYR GLU MET LYS SEQRES 10 A 261 LEU MET ASP LEU ASP VAL GLU GLN LEU GLY ILE PRO GLU SEQRES 11 A 261 GLN GLU TYR SER CYS VAL VAL LYS MET PRO SER GLY GLU SEQRES 12 A 261 PHE ALA ARG ILE CYS ARG ASP LEU SER HIS ILE GLY ASP SEQRES 13 A 261 ALA VAL VAL ILE SER CYS ALA LYS ASP GLY VAL LYS PHE SEQRES 14 A 261 SER ALA SER GLY GLU LEU GLY ASN GLY ASN ILE LYS LEU SEQRES 15 A 261 SER GLN THR SER ASN VAL ASP LYS GLU GLU GLU ALA VAL SEQRES 16 A 261 THR ILE GLU MET ASN GLU PRO VAL GLN LEU THR PHE ALA SEQRES 17 A 261 LEU ARG TYR LEU ASN PHE PHE THR LYS ALA THR PRO LEU SEQRES 18 A 261 SER SER THR VAL THR LEU SER MET SER ALA ASP VAL PRO SEQRES 19 A 261 LEU VAL VAL GLU TYR LYS ILE ALA ASP MET GLY HIS LEU SEQRES 20 A 261 LYS TYR TYR LEU ALA PRO LYS ILE GLU ASP GLU GLU GLY SEQRES 21 A 261 SER SEQRES 1 B 261 MET PHE GLU ALA ARG LEU VAL GLN GLY SER ILE LEU LYS SEQRES 2 B 261 LYS VAL LEU GLU ALA LEU LYS ASP LEU ILE ASN GLU ALA SEQRES 3 B 261 CYS TRP ASP ILE SER SER SER GLY VAL ASN LEU GLN SER SEQRES 4 B 261 MET ASP SER SER HIS VAL SER LEU VAL GLN LEU THR LEU SEQRES 5 B 261 ARG SER GLU GLY PHE ASP THR TYR ARG CYS ASP ARG ASN SEQRES 6 B 261 LEU ALA MET GLY VAL ASN LEU THR SER MET SER LYS ILE SEQRES 7 B 261 LEU LYS CYS ALA GLY ASN GLU ASP ILE ILE THR LEU ARG SEQRES 8 B 261 ALA GLU ASP ASN ALA ASP THR LEU ALA LEU VAL PHE GLU SEQRES 9 B 261 ALA PRO ASN GLN GLU LYS VAL SER ASP TYR GLU MET LYS SEQRES 10 B 261 LEU MET ASP LEU ASP VAL GLU GLN LEU GLY ILE PRO GLU SEQRES 11 B 261 GLN GLU TYR SER CYS VAL VAL LYS MET PRO SER GLY GLU SEQRES 12 B 261 PHE ALA ARG ILE CYS ARG ASP LEU SER HIS ILE GLY ASP SEQRES 13 B 261 ALA VAL VAL ILE SER CYS ALA LYS ASP GLY VAL LYS PHE SEQRES 14 B 261 SER ALA SER GLY GLU LEU GLY ASN GLY ASN ILE LYS LEU SEQRES 15 B 261 SER GLN THR SER ASN VAL ASP LYS GLU GLU GLU ALA VAL SEQRES 16 B 261 THR ILE GLU MET ASN GLU PRO VAL GLN LEU THR PHE ALA SEQRES 17 B 261 LEU ARG TYR LEU ASN PHE PHE THR LYS ALA THR PRO LEU SEQRES 18 B 261 SER SER THR VAL THR LEU SER MET SER ALA ASP VAL PRO SEQRES 19 B 261 LEU VAL VAL GLU TYR LYS ILE ALA ASP MET GLY HIS LEU SEQRES 20 B 261 LYS TYR TYR LEU ALA PRO LYS ILE GLU ASP GLU GLU GLY SEQRES 21 B 261 SER FORMUL 3 HOH *58(H2 O1) HELIX 1 1 GLN A 8 GLU A 17 1 10 HELIX 2 2 LEU A 72 LEU A 79 1 8 HELIX 3 3 SER A 141 HIS A 153 1 13 HELIX 4 4 LEU A 209 THR A 216 1 8 HELIX 5 5 LYS A 217 THR A 219 5 3 HELIX 6 6 GLN B 8 LYS B 20 1 13 HELIX 7 7 LEU B 72 LEU B 79 1 8 HELIX 8 8 SER B 141 SER B 152 1 12 HELIX 9 9 LEU B 209 THR B 216 1 8 HELIX 10 10 LYS B 217 THR B 219 5 3 SHEET 1 AA 5 THR A 59 CYS A 62 0 SHEET 2 AA 5 PHE A 2 LEU A 6 -1 O GLU A 3 N ARG A 61 SHEET 3 AA 5 ILE A 87 ALA A 92 -1 O ILE A 88 N LEU A 6 SHEET 4 AA 5 THR A 98 GLU A 104 -1 O ALA A 100 N ARG A 91 SHEET 5 AA 5 VAL A 111 LYS A 117 -1 O SER A 112 N PHE A 103 SHEET 1 AB 8 LEU A 66 ASN A 71 0 SHEET 2 AB 8 GLU A 25 ILE A 30 -1 O ALA A 26 N VAL A 70 SHEET 3 AB 8 GLY A 34 MET A 40 -1 O ASN A 36 N ASP A 29 SHEET 4 AB 8 SER A 46 ARG A 53 -1 O VAL A 48 N SER A 39 SHEET 5 AB 8 GLY A 245 LEU A 251 -1 O HIS A 246 N THR A 51 SHEET 6 AB 8 VAL A 233 TYR A 239 -1 O LEU A 235 N LEU A 251 SHEET 7 AB 8 THR A 224 SER A 230 -1 O THR A 226 N GLU A 238 SHEET 8 AB 8 CYS A 135 PRO A 140 -1 O CYS A 135 N MET A 229 SHEET 1 AC 4 ASN A 177 LEU A 182 0 SHEET 2 AC 4 VAL A 167 SER A 172 -1 O VAL A 167 N LEU A 182 SHEET 3 AC 4 ALA A 157 CYS A 162 -1 O VAL A 159 N SER A 170 SHEET 4 AC 4 GLN A 204 ALA A 208 -1 O LEU A 205 N ILE A 160 SHEET 1 BA 5 THR B 59 CYS B 62 0 SHEET 2 BA 5 PHE B 2 LEU B 6 -1 O GLU B 3 N ARG B 61 SHEET 3 BA 5 ILE B 87 ALA B 92 -1 O ILE B 88 N LEU B 6 SHEET 4 BA 5 THR B 98 GLU B 104 -1 O ALA B 100 N ARG B 91 SHEET 5 BA 5 SER B 112 LYS B 117 -1 O SER B 112 N PHE B 103 SHEET 1 BB 8 LEU B 66 ASN B 71 0 SHEET 2 BB 8 GLU B 25 SER B 31 -1 O ALA B 26 N VAL B 70 SHEET 3 BB 8 GLY B 34 MET B 40 -1 O GLY B 34 N SER B 31 SHEET 4 BB 8 SER B 46 ARG B 53 -1 O VAL B 48 N SER B 39 SHEET 5 BB 8 GLY B 245 LEU B 251 -1 O HIS B 246 N THR B 51 SHEET 6 BB 8 LEU B 235 TYR B 239 -1 O LEU B 235 N LEU B 251 SHEET 7 BB 8 THR B 224 MET B 229 -1 O THR B 226 N GLU B 238 SHEET 8 BB 8 CYS B 135 PRO B 140 -1 O CYS B 135 N MET B 229 SHEET 1 BC 4 ASN B 177 LYS B 181 0 SHEET 2 BC 4 VAL B 167 SER B 172 -1 O PHE B 169 N ILE B 180 SHEET 3 BC 4 ALA B 157 CYS B 162 -1 O VAL B 159 N SER B 170 SHEET 4 BC 4 VAL B 203 ALA B 208 -1 O VAL B 203 N CYS B 162 CRYST1 82.892 82.892 70.859 90.00 90.00 120.00 P 3 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012064 0.006965 0.000000 0.00000 SCALE2 0.000000 0.013930 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014113 0.00000